Skip to main content

Part of the book series: Current Clinical Pathology ((CCPATH))

  • 702 Accesses

Abstract

Thanks to more and more effective antineoplastic treatments (target therapies and immunotherapy) and the advances in early diagnosis of tumors, the life expectancy of patients suffering from cancer has significantly increased in the last 5 years [1, 2]. The increase in survival has created a population of patients “long survivors” with chronic cancer disease who are more exposed to develop complications of antineoplastic treatments [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.

    Article  CAS  Google Scholar 

  2. De Luca L, Leopardi S, Cavallini C, et al.; EYESHOT Investigators. Contemporary anti-thrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: the EYESHOT Study. Eur Heart J Acute Cardiovasc Care. 2015;4:441–52.

    Article  Google Scholar 

  3. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.

    Article  Google Scholar 

  4. Zamorano JL, Lancellotti P, Munoz DR, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity. Eur Heart J. 2016;37:2768–801.

    Article  Google Scholar 

  5. Koene RJ, Prizment AE, Blaes A, Konety HK. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppina Novo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Russo, A., Novo, G., Lancellotti, P., Pinto, F.J., Giordano, A. (2019). Introduction. In: Russo, A., Novo, G., Lancellotti, P., Giordano, A., Pinto, F. (eds) Cardiovascular Complications in Cancer Therapy. Current Clinical Pathology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-93402-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-93402-0_1

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-93401-3

  • Online ISBN: 978-3-319-93402-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics